Prevention of Renal Osteodistrophy in Primary Care

Ibraim Rudhani, Naim Morina*, Marigonë Zubaku and Ahmet Avdullahu

Received: June 20, 2018;   Published: July 03, 2018

DOI: 10.26717/BJSTR.2018.06.001331

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Introduction: Renal Osteodistrophy is a skeletal change most commonly caused by chronic renal resulting diseases. It is associated with hyperphosphatemia, hypocalcemia, increased secretion of parathyroid hormone, metabolic acidosis and decreased vitamin D activity, which results in skeletal changes.

Purpose of the Research: notification of pathologies of renal osteodystrophy and analysis of collected data.

Materials and Methods: The research was retrospective, conducted at the Hemodialysis Department of Nephrology Clinic, QKUK Prishtina. Part of this study was 89 patients selected in regular hemodialysis sessions. The age of patients ranges from 25 to 80 years, with an average of 57 years. The study was conducted through the collection of data from laboratory documentation of patients who suffered from terminal renal insufficiency.

Results: Out of 89 patients, 42 (47.19%) were women, 47 (52.81%) were males. The most vulnerable age group was 60-69 years old (47.19%), 44 patients with adult phosphorus, 4 patients with decreased phosphorus, 5 were with calcium, 11 with decreased calcium, 5 patients with phosphorus and adult calcium, 1 patient with phosphorus and decreased calcium and 14 patients with increased phosphorus and decreased calcium.

Conclusion: Renal osteodystrophy affects more about 60-69 years of age, while the most affected gender is female and has changes in calcium and phosphorus laboratory values. The most manifested manifestations of both sexes are accompanied by changes in bone remodeling.

Keywords: Renal Osteodystrophy; Chronic Renal Insufficiency

Abstract| Introduction| Research| Results| Discussion| Conclusion| References|